P3 Health Partners
PIII
P3 Health Partners (PIII) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.63
- EPS estimate
- −$1.90
- EPS surprise
- +66.75%
- Revenue surprise
- +2.27%
- Revenue
- $386.4M
- Revenue estimate
- $377.8M
- Reported
- Aug 10, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 10, 2026 | −$1.90 | −$0.63 | +66.75% | $386.4M | SEC |
| Q1 2026 | May 14, 2026 | −$4.85 | $0.32 | +106.60% | $386.4M | SEC |
| Q4 2025 | Mar 26, 2026 | −$8.06 | −$23.02 | −185.49% | $384.8M | SEC |
| Q3 2025 | Nov 14, 2025 | −$5.29 | −$9.67 | −82.71% | $345.3M | SEC |
| Q2 2025 | Aug 14, 2025 | −$5.85 | −$6.23 | −6.41% | $355.8M | SEC |
| Q1 2025 | May 15, 2025 | −$8.16 | −$6.28 | +23.07% | $373.2M | SEC |
| Q4 2024 | Mar 27, 2025 | −$4.10 | −$18.00 | −339.56% | $370.7M | SEC |
| Q3 2024 | Nov 12, 2024 | −$1.84 | −$15.50 | −741.25% | $362.1M | SEC |
| Q2 2024 | Aug 7, 2024 | −$2.20 | −$7.50 | −240.91% | $379.2M | SEC |
| Q1 2024 | May 8, 2024 | −$6.36 | −$8.00 | −25.83% | $388.5M | SEC |
| Q4 2023 | Mar 28, 2024 | −$5.48 | −$11.00 | −100.73% | $346.9M | SEC |
| Q3 2023 | Nov 8, 2023 | −$8.97 | −$6.00 | +33.08% | $288.4M | SEC |
| Q2 2023 | Aug 7, 2023 | −$6.50 | −$4.50 | +30.73% | $329.1M | SEC |
| Q1 2023 | May 10, 2023 | −$23.29 | −$11.00 | +52.76% | $302.1M | SEC |
| Q4 2022 | Mar 31, 2023 | −$45.56 | −$113.00 | −148.04% | $258.2M | SEC |
| Q3 2022 | Nov 14, 2022 | −$34.25 | −$13.50 | +60.58% | $248.3M | — |
| Q2 2022 | Oct 20, 2022 | −$11.50 | −$186.50 | −1521.74% | $269.5M | — |
Quarterly revenue
Frequently asked questions
When did P3 Health Partners (PIII) last report earnings?
P3 Health Partners last reported on Aug 10, 2026, covering fiscal Q2 2026.
Did PIII beat earnings estimates?
Yes. P3 Health Partners reported EPS of −$0.63 for Q2 2026 against a −$1.90 estimate — a 66.75% beat.
How much revenue did PIII report last quarter?
P3 Health Partners reported $386.4M in revenue for Q2 2026, against a consensus estimate of $377.8M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.